Andrew S. Davis - 15 Sep 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
15 Sep 2023
Net transactions value
$0
Form type
4
Filing time
15 Sep 2023, 18:59:01 UTC
Previous filing
10 Jul 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +121,519 +111% $0.000000 231,053 15 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on September 15, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.